NeoGenomics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments.

CEO

Christopher Michael Smith

CEOChristopher Michael Smith

Employees

2,100

Employees2,100

Headquarters

Fort Myers, Florida

HeadquartersFort Myers, Florida

Founded

1998

Founded1998

Employees

2,100

Employees2,100

NEO Key Statistics

Market cap

1.79B

Market cap1.79B

Price-Earnings ratio

-20.00

Price-Earnings ratio-20.00

Dividend yield

—

Dividend yield—

Average volume

696.13K

Average volume696.13K

High today

—

High today—

Low today

—

Low today—

Open price

$14.10

Open price$14.10

Volume

0.00

Volume0.00

52 Week high

$21.22

52 Week high$21.22

52 Week low

$11.03

52 Week low$11.03

NEO News

Yahoo Finance 2d

NeoGenomics May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Wall Street expects a year-over-year increase in earnings on higher revenues when NeoGenomics (NEO) reports results for the quarter ended March 2024. While this...

Analyst ratings

77%

of 13 ratings

Buy

76.9%

Hold

23.1%

Sell